<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Extraction Schema extraction-schema-4 - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Extraction Schema Details for extraction-schema-4</h1>

        <div class="section">
            <h2>Extraction Schema (General Information)</h2>
            <div class="info-section">
                <p><strong>Schema ID:</strong> extraction-schema-4</p>
                <p><strong>Extraction Query:</strong> Extract any mentions of population or ethnic differences in EGFR-activating mutation prevalence in lung cancer and the proposed reasons for higher rates in East Asians, including germline genetic risk, environmental exposures, mutational processes, and demographic covariates; capture effect sizes, mutation spectra, and study details.</p>
            </div>
        </div>

        <div class="section">
            <h2>Extraction Schema (Details)</h2>
            <table>
                <thead>
                    <tr>
                        <th style="width: 20%;">Field Name</th>
                        <th style="width: 15%;">Type</th>
                        <th style="width: 65%;">Description</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>paper_title</strong></td>
                        <td>str</td>
                        <td>Full title of the paper.</td>
                    </tr>
                    <tr>
                        <td><strong>year</strong></td>
                        <td>int</td>
                        <td>Publication year.</td>
                    </tr>
                    <tr>
                        <td><strong>doi_or_pmid</strong></td>
                        <td>str</td>
                        <td>DOI or PMID of the study, if reported.</td>
                    </tr>
                    <tr>
                        <td><strong>study_design</strong></td>
                        <td>str</td>
                        <td>Study type (e.g., sequencing cohort, case-control, cohort, meta-analysis, GWAS, admixture study, environmental epidemiology).</td>
                    </tr>
                    <tr>
                        <td><strong>study_period</strong></td>
                        <td>str</td>
                        <td>Years during which patients/samples were accrued (e.g., 2005-2015).</td>
                    </tr>
                    <tr>
                        <td><strong>country_or_region</strong></td>
                        <td>str</td>
                        <td>Geographic regions/countries of the cohorts (e.g., Japan, China, Korea, Taiwan, US, Europe).</td>
                    </tr>
                    <tr>
                        <td><strong>population_ethnic_groups</strong></td>
                        <td>str</td>
                        <td>Ethnic groups compared or studied (e.g., East Asian, European, admixed, specific nationalities).</td>
                    </tr>
                    <tr>
                        <td><strong>sample_size</strong></td>
                        <td>str</td>
                        <td>Number of patients/samples overall and per subgroup if available (text; include breakdowns).</td>
                    </tr>
                    <tr>
                        <td><strong>tumor_histology</strong></td>
                        <td>str</td>
                        <td>Tumor histology composition (e.g., adenocarcinoma-only, mixed NSCLC).</td>
                    </tr>
                    <tr>
                        <td><strong>smoking_status</strong></td>
                        <td>str</td>
                        <td>Smoking distribution and definitions (never/former/current; pack-years; by ethnicity/sex if available).</td>
                    </tr>
                    <tr>
                        <td><strong>mutation_detection_method</strong></td>
                        <td>str</td>
                        <td>Method used to detect EGFR mutations (e.g., Sanger, ARMS-PCR, qPCR, NGS panel, WES/WGS) and sensitivity.</td>
                    </tr>
                    <tr>
                        <td><strong>egfr_mutation_prevalence_overall</strong></td>
                        <td>str</td>
                        <td>Overall prevalence of activating EGFR mutations (include numerator/denominator and %).</td>
                    </tr>
                    <tr>
                        <td><strong>egfr_mutation_prevalence_by_ethnicity</strong></td>
                        <td>str</td>
                        <td>Prevalence by ethnic group (e.g., East Asian vs non-Asian), with counts/percentages.</td>
                    </tr>
                    <tr>
                        <td><strong>egfr_mutation_prevalence_by_covariates</strong></td>
                        <td>str</td>
                        <td>Prevalence stratified by smoking status, sex, histology, age, or region (include numbers/percents).</td>
                    </tr>
                    <tr>
                        <td><strong>egfr_mutation_subtypes_distribution</strong></td>
                        <td>str</td>
                        <td>Distribution of EGFR mutation subtypes (e.g., exon 19 deletion, L858R, exon 20 insertion, G719X, T790M; include %).</td>
                    </tr>
                    <tr>
                        <td><strong>adjusted_association_ethnicity</strong></td>
                        <td>str</td>
                        <td>Adjusted association between Asian/East Asian ethnicity and EGFR-mutant status (e.g., OR/RR with 95% CI, p-value, covariates adjusted).</td>
                    </tr>
                    <tr>
                        <td><strong>ancestry_analysis</strong></td>
                        <td>str</td>
                        <td>Any admixture/ancestry proportion analyses linking genetic ancestry to EGFR mutation probability (effect sizes, p-values).</td>
                    </tr>
                    <tr>
                        <td><strong>germline_risk_variants_associated</strong></td>
                        <td>str</td>
                        <td>Germline variants/loci associated with EGFR-mutant lung cancer (gene, rsID, locus, risk allele, OR, p-value; note if association is specific to EGFR-mutant, never-smoker, sex-specific; include allele frequencies by population if reported).</td>
                    </tr>
                    <tr>
                        <td><strong>regulatory_variants_in_EGFR</strong></td>
                        <td>str</td>
                        <td>Evidence for regulatory germline variants affecting EGFR expression (e.g., intron 1 CA-SSR1 repeat length, promoter/enhancer SNPs) and their population frequency differences.</td>
                    </tr>
                    <tr>
                        <td><strong>mutational_signatures_TMB</strong></td>
                        <td>str</td>
                        <td>Tumor mutational burden and mutational signatures (e.g., APOBEC, aging, tobacco) associated with EGFR-mutant tumors and their prevalence by ethnicity.</td>
                    </tr>
                    <tr>
                        <td><strong>environmental_exposures_associated</strong></td>
                        <td>str</td>
                        <td>Environmental/occupational exposures linked to EGFR-mutant lung cancer (e.g., cooking oil fumes, biomass/coal, radon, second-hand smoke, PM2.5, indoor air pollution) with effect sizes and whether enriched in East Asian settings.</td>
                    </tr>
                    <tr>
                        <td><strong>hormonal_or_biologic_factors</strong></td>
                        <td>str</td>
                        <td>Evidence for hormonal or biologic factors (e.g., estrogen signaling, sex differences) influencing EGFR mutation risk and any ethnicity-specific data.</td>
                    </tr>
                    <tr>
                        <td><strong>testing_or_selection_bias</strong></td>
                        <td>str</td>
                        <td>Notes on diagnostic era, testing method sensitivity, referral patterns, or other biases that could influence observed prevalence differences.</td>
                    </tr>
                    <tr>
                        <td><strong>authors_proposed_mechanisms</strong></td>
                        <td>str</td>
                        <td>Concise summary of mechanisms proposed by authors to explain higher EGFR mutation rates in East Asians (categorize as germline, environmental, mutational process, demographic, or bias).</td>
                    </tr>
                    <tr>
                        <td><strong>counter_evidence_or_null_results</strong></td>
                        <td>str</td>
                        <td>Findings that contradict common explanations or show no association after adjustment (include statistics).</td>
                    </tr>
                    <tr>
                        <td><strong>key_statistics</strong></td>
                        <td>str</td>
                        <td>Most important quantitative results relevant to the question (e.g., ORs, HRs, CIs, p-values, absolute % differences).</td>
                    </tr>
                </tbody>
            </table>
        </div>

    </div>
</body>
</html>